Details for New Drug Application (NDA): 016792
✉ Email this page to a colleague
NDA 016792 describes SURMONTIL, which is a drug marketed by Odyssey Pharms and is included in one NDA. Additional details are available on the SURMONTIL profile page.
The generic ingredient in SURMONTIL is trimipramine maleate. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the trimipramine maleate profile page.
The generic ingredient in SURMONTIL is trimipramine maleate. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the trimipramine maleate profile page.
Summary for 016792
| Tradename: | SURMONTIL |
| Applicant: | Odyssey Pharms |
| Ingredient: | trimipramine maleate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 016792
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Sep 15, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
